Feedback / Questions
JR-446 - JCR Pharma
https://www.businesswire.com/news/home/20250624122250/en/Notice-of-Orphan-Drug-Designation-for-JR-446-for-Mucopolysaccharidosis-Type-IIIB-by-European-Commission-EC
Jun 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next